Welcome to our
Media library

Access a range of clinical educational content, to all the clinical content available about for both macula and peripheral treatments, including: clinical articles, clinical videos, treatment guidelines…

SEARCH

Advanced search

TYPE OF DOCUMENTS

Subthreshold laser therapy guidelines for retinal diseases

Subthreshold laser therapy guidelines for retinal diseases

19/09/2022
Subthreshold laser therapy has been utilised in clinical practice for more than three decades, and numerous randomised and real-life studies has proven its efficacy and safety in various retinal diseases. However, despite decades of usage, we still do not have a standard protocol for subthreshold laser applications and settings.
Dr Wu 2022 EURETINA
Play button

Subthreshold laser: a new hope for macular degeneration?

16/09/2022
Dr Lihteh Wu presents why Subthreshold laser can be consider as a new hope for macular degeneration.
Dr Fong EURETINA 2022
Play button

Best practices in subthreshold laser treatment, which laser should be used and how?

16/09/2022
Dr Kenneth Fong presents best practices in subthreshold laser treatment to easily understand which laser should be used and how.
Dr Filloy EURTINA 2022
Play button

Central Serous Chorioretinopathy: effectiveness and safety without verteporfin?

16/09/2022
During 2022 EURETINA congress, Dr Alejandro Filloy explains how to treat CSC safely and effectively without verteporfin.
Victor Chong EURETINA 2022
Play button

Retinal laser treatments in Covid 19 era: from PDR to DME

16/09/2022
During 2022 EURETINA symposium, Dr Victor Chong presents the use of retinal laser treatments in COVID 19 era, from PDR to DME.
CSC-verteporfin-min

Central Serous Chorioretinopathy: Can it be treated without Visudyne?

03/05/2022
Given the difficulty of obtaining verteporfin for chronic CSCR, it is worth considering subthreshold laser therapy as an alternative given its comparable efficacy and practical advantages. We know that the prognosis for this disease depends on the level of disease progression, so a therapeutic option that allows for an undelayed treatment is extremely interesting.